{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:12:38Z","timestamp":1788635558426,"version":"build-2803163510"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00335-026-10274-9","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:56:03Z","timestamp":1788630963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-6331","authenticated-orcid":false,"given":"Anirban Goutam","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit Kumar","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi Maria","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilash Valsala","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nishu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"10274_CR1","doi-asserted-by":"publisher","DOI":"10.1177\/03915603261457521","author":"A Agrawal","year":"2025","unstructured":"Agrawal A, Goel A, Goyal SK, Pal M (2025) Multiomics empowers predictive drug resistance in advanced prostate cancer. Urologia (Basel). https:\/\/doi.org\/10.1177\/03915603261457521","journal-title":"Urologia (Basel)"},{"issue":"3","key":"10274_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13723","volume":"75","author":"G Akkus","year":"2021","unstructured":"Akkus G, Izol V, Ok F, Evran M, Inceman M, Erdogan S, Kaplan HM, Sert M, Tetiker T (2021) Possible role of the receptor of advanced glycation end products (RAGE) in the clinical course of prostate neoplasia in patients with and without type 2 diabetes mellitus. Int J Clin Pract 75(3):e13723","journal-title":"Int J Clin Pract"},{"key":"10274_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1072739","volume":"12","author":"Z Akter","year":"2023","unstructured":"Akter Z, Salamat N, Ali MY, Zhang L (2023) The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy. Front Oncol 12:1072739","journal-title":"Front Oncol"},{"issue":"3","key":"10274_CR4","first-page":"2937","volume":"145","author":"S Albaradei","year":"2025","unstructured":"Albaradei S (2025) AI-driven approaches to utilization of multi-omics data for personalized diagnosis and treatment of cancer: a comprehensive review. Comput Model Eng Sci 145(3):2937","journal-title":"Comput Model Eng Sci"},{"issue":"8","key":"10274_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081538","volume":"16","author":"A Alhajahjeh","year":"2024","unstructured":"Alhajahjeh A, Al-Faouri R, Bahmad HF, Bader T, Dobbs RW, Abdulelah AA, Abou-Kheir W, Davicioni E, Lee DI, Shahait M (2024) From diabetes to oncology: glucagon-like peptide-1 (GLP-1) receptor agonist\u2019s dual role in prostate cancer. Cancers 16(8):1538","journal-title":"Cancers"},{"issue":"8","key":"10274_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18081227","volume":"18","author":"R Al-Hakm","year":"2026","unstructured":"Al-Hakm R, Altaie AM, Boghossian A, Bendardaf R, Talaat IM, Hamoudi R (2026) NF-\u03baB signaling in prostate cancer progression: inflammatory mediators, survival pathways, and regulatory axes. Cancers 18(8):1227","journal-title":"Cancers"},{"issue":"1","key":"10274_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s42003-023-05289-w","volume":"6","author":"A Ali","year":"2023","unstructured":"Ali A, Mekhaeil B, Biziotis O-D, Tsakiridis EE, Ahmadi E, Wu J, Wang S, Singh K, Menjolian G, Mesci A, Liu S, Berg T, Bramson JL, Steinberg GR, Tsakiridis T, Farrell T (2023) The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy. Commun Biol 6(1):919","journal-title":"Commun Biol"},{"issue":"7","key":"10274_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071679","volume":"14","author":"I AlZaim","year":"2022","unstructured":"AlZaim I, Al-Saidi A, Hammoud SH, Darwiche N, Al-Dhaheri Y, Eid AH, El-Yazbi AF (2022) Thromboinflammatory processes at the nexus of metabolic dysfunction and prostate cancer: the emerging role of periprostatic adipose tissue. Cancers (Basel) 14(7):1679","journal-title":"Cancers (Basel)"},{"key":"10274_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/2049-3002-2-12","volume":"2","author":"S Andrzejewski","year":"2014","unstructured":"Andrzejewski S, Gravel SP, Pollak M, St-Pierre J (2014) Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab 2:12. https:\/\/doi.org\/10.1186\/2049-3002-2-12","journal-title":"Cancer Metab"},{"issue":"1","key":"10274_CR10","doi-asserted-by":"publisher","first-page":"38585","DOI":"10.1038\/s41598-025-22556-4","volume":"15","author":"N Ao","year":"2025","unstructured":"Ao N, Li J, Wang Q, Du J, Jin S, Yang J (2025) Clinical and laboratory characteristics of novel diabetes subgroups: a systematic review and meta-analysis. Sci Rep 15(1):38585. https:\/\/doi.org\/10.1038\/s41598-025-22556-4","journal-title":"Sci Rep"},{"issue":"10","key":"10274_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102984","volume":"12","author":"M Archer","year":"2020","unstructured":"Archer M, Dogra N, Kyprianou N (2020) Inflammation as a driver of prostate cancer metastasis and therapeutic resistance. Cancers (Basel) 12(10):2984","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10274_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14192132","volume":"14","author":"A Asiri","year":"2024","unstructured":"Asiri A, Al Qarni A, Bakillah A (2024) The interlinking metabolic association between type 2 diabetes mellitus and cancer: molecular mechanisms and therapeutic insights. Diagnostics (Basel) 14(19):2132","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10274_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02320-y","volume":"24","author":"E Atas","year":"2025","unstructured":"Atas E, Berchtold K, Schlederer M, Prodinger S, Sternberg F, Pucci P, Steel C, Matthews JD, James ER, Trachtov\u00e1 K, Moazzami AA, Artamonova N, Melchior F, Redmer T, Timelthaler G, Pohl EE, Turner SD, Heidegger I, Krueger M, Resch U, Kenner L, Philippe C (2025) The anti-diabetic PPAR\u03b3 agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer. Mol Cancer 24(1):134","journal-title":"Mol Cancer"},{"issue":"1","key":"10274_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000872","volume":"7","author":"SL Au Yeung","year":"2019","unstructured":"Au Yeung SL, Schooling CM (2019) Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study. BMJ Open Diabetes Res Care 7(1):e000872","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10274_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004089","author":"RC Augustin","year":"2022","unstructured":"Augustin RC, Leone RD, Naing A, Fong L, Bao R, Luke JJ (2022) Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-004089","journal-title":"J Immunother Cancer"},{"key":"10274_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/frlct.2024.1487377","volume":"3","author":"LR Avula","year":"2024","unstructured":"Avula LR, Grodzinski P (2024) How organ-on-a-chip is advancing cancer research and oncology-a cancer hallmarks\u2019 perspective. Front Lab Chip Technol 3:1487377","journal-title":"Front Lab Chip Technol"},{"issue":"2","key":"10274_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/pcan.2012.40","volume":"16","author":"D Bansal","year":"2013","unstructured":"Bansal D, Bhansali A, Kapil G, Undela K, Tiwari P (2013) Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies. Prostate Cancer Prostatic Dis 16(2):151\u2013158","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10274_CR18","first-page":"1741","volume":"5","author":"JM Bao","year":"2015","unstructured":"Bao JM, He MY, Liu YW, Lu YJ, Hong YQ, Luo HH, Jiang Y (2015) AGE\/RAGE\/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation. Am J Cancer Res 5(5):1741\u20131750","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10274_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.molmed.2010.09.006","volume":"17","author":"YS Barach","year":"2011","unstructured":"Barach YS, Lee JS, Zang X (2011) T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics. Trends Mol Med 17(1):47\u201355. https:\/\/doi.org\/10.1016\/j.molmed.2010.09.006","journal-title":"Trends Mol Med"},{"issue":"6","key":"10274_CR20","doi-asserted-by":"publisher","first-page":"R187","DOI":"10.1530\/ERC-12-0085","volume":"19","author":"DA Barron","year":"2012","unstructured":"Barron DA, Rowley DR (2012) The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer 19(6):R187\u2013R204","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"10274_CR21","doi-asserted-by":"publisher","first-page":"e1914689","DOI":"10.1001\/jamanetworkopen.2019.14689","volume":"2","author":"K Beckmann","year":"2019","unstructured":"Beckmann K, Crawley D, Nordstr\u00f6m T, Aly M, Olsson H, Lantz A, Binti Abd Jalal N, Garmo H, Adolfsson J, Van Hemelrijck M, Eklund M (2019) Association between antidiabetic medications and prostate-specific antigen levels and biopsy results. JAMA Netw Open 2(11):e1914689","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10274_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/jmp5010007","volume":"5","author":"HS Black","year":"2024","unstructured":"Black HS (2024) Oxidative stress and ROS link diabetes and cancer. J Mol Pathol 5(1):96\u2013119","journal-title":"J Mol Pathol"},{"issue":"21","key":"10274_CR23","doi-asserted-by":"publisher","first-page":"7658","DOI":"10.1158\/1078-0432.CCR-05-0460","volume":"11","author":"JL Boddy","year":"2005","unstructured":"Boddy JL, Fox SB, Han C, Campo L, Turley H, Kanga S, Malone PR, Harris AL (2005) The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. Clin Cancer Res 11(21):7658\u20137663","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10274_CR24","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","volume":"47","author":"S Bonovas","year":"2004","unstructured":"Bonovas S, Filioussi K, Tsantes A (2004) Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47(6):1071\u20131078","journal-title":"Diabetologia"},{"issue":"1","key":"10274_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45158-4","volume":"13","author":"A B\u00f8rretzen","year":"2023","unstructured":"B\u00f8rretzen A, Reis\u00e6ter LA, Ringheim A, Gravdal K, Haukaas SA, Fasmer KE, Reis\u00e6ter LAR, Haldorsen IHS, Beisland C, Akslen LA, Halvorsen OJ (2023) Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer. Sci Rep 13(1):17949","journal-title":"Sci Rep"},{"issue":"4","key":"10274_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/dmrr.2582","volume":"31","author":"H Cai","year":"2015","unstructured":"Cai H, Xu Z, Xu T, Yu B, Zou Q (2015) Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies. Diabetes Metab Res Rev 31(4):336\u2013343","journal-title":"Diabetes Metab Res Rev"},{"key":"10274_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217694","volume":"622","author":"S Cai","year":"2025","unstructured":"Cai S, Deng Y, Zou Z, Tian W, Tang Z, Li J, Tan Z, Wu Z, Han Z, Feng Y, Liu R, Zhu X, Wu Y, Xiao H, He H, Ye J, Zhong W, Wen B (2025) Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP\/PKG pathway activation. Cancer Lett 622:217694","journal-title":"Cancer Lett"},{"issue":"8","key":"10274_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579\u2013591","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10274_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167841","volume":"1871","author":"J Camps","year":"2025","unstructured":"Camps J, Jim\u00e9nez-Franco A, Garc\u00eda-Pablo R, Joven J, Arenas M (2025) Artificial intelligence-driven integration of multi-omics and radiomics: a new hope for precision cancer diagnosis and prognosis. Biochimica et Biophysica Acta\u2013Mol Basis Dis 1871(6):167841","journal-title":"Biochimica et Biophysica Acta\u2013Mol Basis Dis"},{"issue":"5","key":"10274_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","volume":"19","author":"BS Carver","year":"2011","unstructured":"Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Carver B, Arora V, Le C, Koutcher J, Scardino P, Rosen N, Sawyers C, Scher H (2011) Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 19(5):575\u2013586","journal-title":"Cancer Cell"},{"issue":"1","key":"10274_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00400-1","volume":"27","author":"J Catapano","year":"2022","unstructured":"Catapano J, Luty M, Wr\u00f3bel T, Pude\u0142ek M, Piwowarczyk K, K\u0119dracka-Krok S, Siedlar M, Madeja Z, Czy\u017c J (2022) Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress. Cell Mol Biol Lett 27(1):100. https:\/\/doi.org\/10.1186\/s11658-022-00400-1","journal-title":"Cell Mol Biol Lett"},{"issue":"5350","key":"10274_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1126\/science.279.5350.563","volume":"279","author":"JM Chan","year":"1998","unstructured":"Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279(5350):563\u2013566","journal-title":"Science"},{"issue":"6","key":"10274_CR33","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"C-H Chang","year":"2015","unstructured":"Chang C-H, Qiu J, O\u2019Sullivan D, Buck MD, Noguchi T, Curtis JD, Van Der Windt GJ (2015) Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162(6):1229\u20131241","journal-title":"Cell"},{"key":"10274_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2026.116349","author":"W Chang","year":"2026","unstructured":"Chang W, Zhang W, Li K, Huang P (2026) Integrative spatial multi-omics reveals the tumor ecosystem: from mechanistic insights to therapeutic strategies. iScience. https:\/\/doi.org\/10.1016\/j.isci.2026.116349","journal-title":"iScience"},{"issue":"2","key":"10274_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/ERC-21-0107","volume":"29","author":"CH Chau","year":"2022","unstructured":"Chau CH, Till C, Price DK, Goodman PJ, Neuhouser ML, Pollak MN, Thompson IM, Figg WD (2022) Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial. Endocr Relat Cancer 29(2):99\u2013109","journal-title":"Endocr Relat Cancer"},{"key":"10274_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.diabres.2018.04.022","volume":"141","author":"M Chen","year":"2018","unstructured":"Chen M, Luo Y, Yang S, Xu L, Li N, Li H, Qu S (2018) Association of diabetes mellitus with prostate cancer grade and prostate-specific antigen in Chinese biopsy population. Diabetes Res Clin Pract 141:80\u201387","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10274_CR37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12935-021-02043-2","volume":"21","author":"C Chen","year":"2021","unstructured":"Chen C, Wang H, Geng X, Zhang D, Zhu Z, Zhang G, Hou J (2021) Metformin exerts anti-AR-negative prostate cancer activity via AMPK\/autophagy signaling pathway. Cancer Cell Int 21(1):404","journal-title":"Cancer Cell Int"},{"issue":"10","key":"10274_CR38","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1158\/2767-9764.CRC-24-0210","volume":"4","author":"R Chen","year":"2024","unstructured":"Chen R, Tang L, Melendy T, Yang L, Goodison S, Sun Y (2024) Prostate cancer progression modeling provides insight into dynamic molecular changes associated with progressive disease states. Cancer Res Commun 4(10):2783\u20132798","journal-title":"Cancer Res Commun"},{"issue":"1","key":"10274_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18010151","volume":"18","author":"P Chen","year":"2025","unstructured":"Chen P, Chen J, Zhan P, Ye X, Zhao L, Zhang Z, Zuo J, Shi H, Li X, Fu Y, Wang H, Fu S, Wu S (2025) Targeting cancer-associated fibroblasts in prostate cancer: recent advances and therapeutic opportunities. Cancers (Basel) 18(1):151","journal-title":"Cancers (Basel)"},{"key":"10274_CR40","doi-asserted-by":"crossref","unstructured":"Chen J-Y, Xue Y-T, Lin B, Huang X-Y, Lin F, Chen D-N, Zheng Q-S (2026) A feedback mechanism from prostate cancer cells to macrophages, reinforced by STAT1, regulates tumor progression and resistance to radiotherapy. Cell Death Dis","DOI":"10.1038\/s41419-026-08577-5"},{"issue":"11","key":"10274_CR41","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/biom12111590","volume":"12","author":"SY Choi","year":"2022","unstructured":"Choi SY, Ribeiro CF, Wang Y, Loda M, Plymate SR, Uo T (2022) Druggable metabolic vulnerabilities are exposed and masked during progression to castration resistant prostate cancer. Biomolecules 12(11):1590","journal-title":"Biomolecules"},{"issue":"7","key":"10274_CR42","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2337\/dci20-0022","volume":"43","author":"WK Chung","year":"2020","unstructured":"Chung WK, Erion K, Florez JC, Hattersley AT, Hivert M-F, Lee CG, McCarthy MI, Nolan JJ, Norris JM, Philipson L, McElvaine AT, Cefalu WT, Rich SS, Franks PW, Pearson ER (2020) Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43(7):1617\u20131635","journal-title":"Diabetes Care"},{"key":"10274_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112439","author":"M Cioce","year":"2020","unstructured":"Cioce M, Pulito C, Strano S, Blandino G, Fazio VM (2020) Metformin: metabolic rewiring faces tumor heterogeneity. Cells. https:\/\/doi.org\/10.3390\/cells9112439","journal-title":"Cells"},{"issue":"1","key":"10274_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1590\/S1677-5538.IBJU.2015.01.15","volume":"41","author":"LL Corr\u00eaa","year":"2015","unstructured":"Corr\u00eaa LL, Vieira L, Lima GAB, Gabrich R, Miranda LCDd, Gadelha MR (2015) Insulin-like growth factor (IgF)-I, IgF binding protein-3, and prostate cancer: correlation with gleason score. Int Braz J Urol 41(1):110\u2013115","journal-title":"Int Braz J Urol"},{"issue":"3","key":"10274_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbadis.2013.06.003","volume":"1842","author":"S Corvera","year":"2014","unstructured":"Corvera S, Gealekman O (2014) Adipose tissue angiogenesis: impact on obesity and type-2 diabetes. Biochim Biophys Acta 1842(3):463\u2013472. https:\/\/doi.org\/10.1016\/j.bbadis.2013.06.003","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10274_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1476-4598-5-17","volume":"5","author":"LC Costello","year":"2006","unstructured":"Costello LC, Franklin RB (2006) The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 5(1):17","journal-title":"Mol Cancer"},{"issue":"1","key":"10274_CR47","first-page":"1008","volume":"1","author":"KA Coughlan","year":"2013","unstructured":"Coughlan KA, Valentine RJ, Ruderman NB, Saha AK (2013) Nutrient excess in AMPK downregulation and insulin resistance. J Endocrinol Diab Obes 1(1):1008","journal-title":"J Endocrinol Diab Obes"},{"key":"10274_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106094","volume":"177","author":"H Cui","year":"2022","unstructured":"Cui H, Wang Y, Yang S, He G, Jiang Z, Gang X, Wang G (2022) Antidiabetic medications and the risk of prostate cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Pharmacol Res 177:106094","journal-title":"Pharmacol Res"},{"issue":"8","key":"10274_CR49","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a014217","volume":"3","author":"CV Dang","year":"2013","unstructured":"Dang CV (2013) MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med 3(8):a014217","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10274_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biology14050544","author":"B Dang","year":"2025","unstructured":"Dang B, Liang L, Li Z, Luo J, Zhong S (2025) Bolstering CD8(+) T cells\u2019 antitumor immunity: a promising strategy to improve the response to advanced prostate cancer treatment. Biology (Basel). https:\/\/doi.org\/10.3390\/biology14050544","journal-title":"Biology (Basel)"},{"issue":"8","key":"10274_CR51","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00125-016-3972-x","volume":"59","author":"R Dankner","year":"2016","unstructured":"Dankner R, Boffetta P, Keinan-Boker L, Balicer RD, Berlin A, Olmer L, Murad H, Silverman B, Hoshen M, Freedman LS (2016) Diabetes, prostate cancer screening and risk of low-and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men. Diabetologia 59(8):1683\u20131691","journal-title":"Diabetologia"},{"issue":"12","key":"10274_CR52","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux K, Delgoffe GM (2021) Metabolic barriers to cancer immunotherapy. Nat Rev Immunol 21(12):785\u2013797","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10274_CR53","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1210\/jc.2004-0804","volume":"89","author":"S Dhindsa","year":"2004","unstructured":"Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89(11):5462\u20135468. https:\/\/doi.org\/10.1210\/jc.2004-0804","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"10274_CR54","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1097\/CM9.0000000000003844","volume":"138","author":"H Ding","year":"2025","unstructured":"Ding H, Meng Q, Zhou J, Chen L, Huang J, Zhao B, Xu L (2025) Revisiting the role of metabolic reprogramming as a contributor to prostate cancer disease progression. Chin Med J 138(24):3381\u20133391","journal-title":"Chin Med J"},{"issue":"1","key":"10274_CR55","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.immuni.2011.04.019","volume":"35","author":"MK Donkor","year":"2011","unstructured":"Donkor MK, Sarkar A, Savage PA, Franklin RA, Johnson LK, Jungbluth AA, Donkor M, Savage P, Franklin R, Johnson L, Jungbluth A, Allison J, Li M, Li MO (2011) T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-\u03b21 cytokine. Immunity 35(1):123\u2013134","journal-title":"Immunity"},{"key":"10274_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16234010","author":"A Drab","year":"2024","unstructured":"Drab A, Wdowiak K, Kanadys W, Zaj\u0105czkowski K, Koczkodaj P, Religioni U, Borowska M, \u0141o\u015b M, Lozano-Lorca M (2024) Diabetes mellitus and prostate cancer risk-a systematic review and meta-analysis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16234010","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10274_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091576","volume":"17","author":"J Drewa","year":"2025","unstructured":"Drewa J, Lazar-Juszczak K, Adamowicz J, Juszczak K (2025) patients receiving GLP-1 agonists be at lower risk of prostate cancer aggressiveness and progression? Cancers 17(9):1576","journal-title":"Cancers"},{"issue":"6016","key":"10274_CR58","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ, Taylor R (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331(6016):456\u2013461","journal-title":"Science"},{"issue":"10","key":"10274_CR59","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1084\/jem.20081188","volume":"205","author":"A El-Osta","year":"2008","unstructured":"El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205(10):2409\u20132417","journal-title":"J Exp Med"},{"issue":"2","key":"10274_CR60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/BF03346748","volume":"36","author":"K Esposito","year":"2013","unstructured":"Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino M, Parretta E, Maiorino MI, Lenzi A, Giugliano D (2013) Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest 36(2):132\u2013139","journal-title":"J Endocrinol Invest"},{"key":"10274_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.coemr.2020.02.007","volume":"10","author":"D Est\u00e8ve","year":"2020","unstructured":"Est\u00e8ve D, Roumigui\u00e9 M, Manceau C, Milhas D, Muller C (2020) Periprostatic adipose tissue: a heavy player in prostate cancer progression. Curr Opin Endocr Metab Res 10:29\u201335","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"15","key":"10274_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157475","volume":"26","author":"Y Fatima","year":"2025","unstructured":"Fatima Y, Jobre KN, Gomez-Gomez E, Ma\u0142kiewicz B, Vlahou A, Mokou M, Mischak H, Frantzi M, Jankowski V (2025) Omics-mediated treatment for advanced prostate cancer: moving towards precision oncology. Int J Mol Sci 26(15):7475","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10274_CR63","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41416-020-0910-y","volume":"123","author":"X Feng","year":"2020","unstructured":"Feng X, Song M, Preston MA, Ma W, Hu Y, Pernar CH, Stopsack KH, Ebot EM, Fu BC, Zhang Y, Li N, Dai M, Liu L, Giovannucci EL, Mucci LA (2020) The association of diabetes with risk of prostate cancer defined by clinical and molecular features. Br J Cancer 123(4):657\u2013665. https:\/\/doi.org\/10.1038\/s41416-020-0910-y","journal-title":"Br J Cancer"},{"issue":"19","key":"10274_CR64","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","volume":"72","author":"T Fiaschi","year":"2012","unstructured":"Fiaschi T, Marini A, Giannoni E, Taddei ML, Gandellini P, De Donatis A, Lanciotti M, Serni S, Cirri P, Chiarugi P (2012) Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res 72(19):5130\u20135140","journal-title":"Cancer Res"},{"key":"10274_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27052357","author":"S Fiorini","year":"2026","unstructured":"Fiorini S, Maras B, Mignogna G, Perugini M, Retali F, Meschiari G, Macone A, Botta S, Altieri F, Eufemi M, Minacori M (2026) ROS-fueled allies: STAT3, PKM2, and HIF-1\u03b1 influencing energy metabolism in hormone-independent cancers. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms27052357","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10274_CR66","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nri2808","volume":"10","author":"RA Flavell","year":"2010","unstructured":"Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Lim\u00f3n P (2010) The polarization of immune cells in the tumour environment by TGF\u03b2. Nat Rev Immunol 10(8):554\u2013567","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10274_CR67","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.90712","volume":"17","author":"M Fleifel","year":"2025","unstructured":"Fleifel M, El Alam A (2025) Diabetes mellitus and the prostate: the odd pairing. Cureus 17(8):e90712. https:\/\/doi.org\/10.7759\/cureus.90712","journal-title":"Cureus"},{"issue":"11","key":"10274_CR68","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.21037\/tau-2025-502","volume":"14","author":"Y-Q Fu","year":"2025","unstructured":"Fu Y-Q, Wang F-X, Wu J-F (2025) Multi-omics characterization of metabolic and immune interactions in prostate cancer. Transl Androl Urol 14(11):3729\u20133744","journal-title":"Transl Androl Urol"},{"issue":"9","key":"10274_CR69","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1158\/1940-6207.Capr-13-0424","volume":"7","author":"S Gandini","year":"2014","unstructured":"Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, DeCensi A, Szabo E (2014) Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res (Phila) 7(9):867\u2013885. https:\/\/doi.org\/10.1158\/1940-6207.Capr-13-0424","journal-title":"Cancer Prev Res (Phila)"},{"key":"10274_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2026.108307","author":"K Gao","year":"2026","unstructured":"Gao K, Li Y, Song X, Ju M, Liu W, Xu J, Jie L, Zhang H, Wei Q, Zhao L (2026) Hypoxia-driven immune resistance to anti-PD-1\/PD-L1 therapy: mechanistic insights and therapeutic opportunities. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2026.108307","journal-title":"Pharmacol Res"},{"issue":"1","key":"10274_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1023\/A:1008822917449","volume":"9","author":"E Giovannucci","year":"1998","unstructured":"Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1998) Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 9(1):3\u20139","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10274_CR72","first-page":"207","volume":"60","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60(4):207\u2013221","journal-title":"CA Cancer J Clin"},{"key":"10274_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030596","author":"N G\u00f3mez-Cebri\u00e1n","year":"2022","unstructured":"G\u00f3mez-Cebri\u00e1n N, Poveda JL, Pineda-Lucena A, Puchades-Carrasco L (2022) Metabolic phenotyping in prostate cancer using multi-omics approaches. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14030596","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10274_CR74","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-06-0477","volume":"15","author":"Z Gong","year":"2006","unstructured":"Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Thompson IM (2006) Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomark Prevent 15(10):1977\u20131983","journal-title":"Cancer Epidemiol Biomark Prevent"},{"key":"10274_CR75","doi-asserted-by":"crossref","unstructured":"Gonthier K, Poluri RTK, Audet-Walsh EJTJoSB, Biology M (2019) Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer 191: 105367","DOI":"10.1016\/j.jsbmb.2019.04.016"},{"issue":"5","key":"10274_CR76","doi-asserted-by":"publisher","first-page":"F47","DOI":"10.1530\/ERC-12-0067","volume":"19","author":"M Grossmann","year":"2012","unstructured":"Grossmann M, Wittert G (2012) Androgens, diabetes and prostate cancer. Endocr Relat Cancer 19(5):F47\u2013F62","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10274_CR77","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1210\/jc.2007-2177","volume":"93","author":"M Grossmann","year":"2008","unstructured":"Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, MacIsaac RJ, Clarke S, Jerums G (2008) Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 93(5):1834\u20131840","journal-title":"J Clin Endocrinol Metab"},{"key":"10274_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563303","volume":"16","author":"X-Y Gu","year":"2025","unstructured":"Gu X-Y, Yang J-L, Lai R, Zhou Z-J, Tang D, Hu L, Zhao L-J (2025) Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives. Front Immunol 16:1563303","journal-title":"Front Immunol"},{"issue":"6","key":"10274_CR79","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","volume":"22","author":"Y Guo","year":"2021","unstructured":"Guo Y, Xie Y-Q, Gao M, Zhao Y, Franco F, Wenes M, Siddiqui I, Bevilacqua A, Wang H, Feng B, Xie X, Sabatel CM, Tschumi B, Chaiboonchoe A, Wang Y, Li W, Xiao W, Held W, Romero P, Ho P-C, Tang L, Yang H (2021) Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity. Nat Immunol 22(6):746\u2013756","journal-title":"Nat Immunol"},{"issue":"24","key":"10274_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249660","volume":"21","author":"A Guth","year":"2020","unstructured":"Guth A, Monk E, Agarwal R, Bergman BC, Zemski-Berry KA, Minic A, Jordan K, Schlaepfer IR (2020) Targeting fat oxidation in mouse prostate cancer decreases tumor growth and stimulates anti-cancer immunity. Int J Mol Sci 21(24):9660","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10274_CR81","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30(2):214\u2013226","journal-title":"Mol Cell"},{"issue":"10","key":"10274_CR82","volume":"13","author":"S Hachem","year":"2024","unstructured":"Hachem S, Yehya A, El Masri J, Mavingire N, Johnson JR, Dwead AM, Kattour N, Bouchi Y, Kobeissy F, Mechref Y, Abou-Kheir W, Woods-Burnham L, Rais-Bahrami S (2024) Contemporary update on clinical and experimental prostate cancer biomarkers: a multi-omics-focused approach to detection and risk stratification. Biology (Basel) 13(10):762","journal-title":"Biology (Basel)"},{"key":"10274_CR83","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8580043","author":"C Han","year":"2022","unstructured":"Han C, Deng Y, Xu W, Liu Z, Wang T, Wang S, Liu J, Liu X (2022) The roles of tumor-associated macrophages in prostate cancer. J Oncol. https:\/\/doi.org\/10.1155\/2022\/8580043","journal-title":"J Oncol"},{"issue":"3","key":"10274_CR84","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.7150\/ijbs.121033","volume":"22","author":"X Hao","year":"2026","unstructured":"Hao X, Chao Z, Peng H, Guo X, Zheng S, Zhang C, Ding H, Wang Y, Xi Z, Gao Y, Qu G, Zhu Y, Chen Z, Lan P, Li L, Wang Z (2026) Metformin sensitizes PTEN-deficient prostate cancer to PARP inhibitors by rebuilding NADP(+) homeostasis. Int J Biol Sci 22(3):1346\u20131368. https:\/\/doi.org\/10.7150\/ijbs.121033","journal-title":"Int J Biol Sci"},{"key":"10274_CR85","doi-asserted-by":"crossref","unstructured":"He D, Hu H, Xiao K, Zhang Y, Cheng Y, Jiao S, Yan X (2026) Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFLARE-seq and mxFRIZNGRND. Nat Commun","DOI":"10.1038\/s41467-026-69347-7"},{"issue":"27","key":"10274_CR86","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1038\/s41388-019-0805-7","volume":"38","author":"L Ippolito","year":"2019","unstructured":"Ippolito L, Morandi A, Taddei ML, Parri M, Comito G, Iscaro A, Raspollini MR, Magherini F, Rapizzi E, Muccioli GG, Sonveaux P, Chiarugi P, Giannoni E, Masquelier J (2019) Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer. Oncogene 38(27):5339\u20135355","journal-title":"Oncogene"},{"issue":"1","key":"10274_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02721-x","volume":"4","author":"LB Jarvis","year":"2021","unstructured":"Jarvis LB, Rainbow DB, Coppard V, Howlett SK, Georgieva Z, Davies JL, Mullay HK, Hester J, Ashmore T, Grist JT, Coles AJ, Mousa HS, Pluchino S, Mahbubani KT, Griffin JL, Saeb-Parsy K, Issa F, Peruzzotti-Jametti L, Wicker LS, Jones JL, Van Den Bosch A (2021) Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73. Commun Biol 4(1):1186","journal-title":"Commun Biol"},{"issue":"11","key":"10274_CR89","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1172\/JCI96268","volume":"128","author":"P Jayaprakash","year":"2018","unstructured":"Jayaprakash P, Ai M, Liu A, Budhani P, Bartkowiak T, Sheng J, Ager C, Nicholas C, Jaiswal AR, Shah K, Balasubramanyam S, Li N, Wang G, Ning J, Zal A, Zal T, Curran MA, Sun Y (2018) Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy. J Clin Invest 128(11):5137\u20135149","journal-title":"J Clin Invest"},{"issue":"7400","key":"10274_CR90","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"S-M Jeon","year":"2012","unstructured":"Jeon S-M, Chandel NS, Hay N (2012) AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485(7400):661\u2013665","journal-title":"Nature"},{"issue":"1","key":"10274_CR91","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2022.2156497","volume":"26","author":"JK Jo","year":"2023","unstructured":"Jo JK, Song HK, Heo Y, Kim MJ, Kim YJ (2023) Risk analysis of metformin use in prostate cancer: a national population-based study. Aging Male 26(1):2156497","journal-title":"Aging Male"},{"issue":"4","key":"10274_CR92","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/carcin\/bgn032","volume":"29","author":"S-N Jung","year":"2008","unstructured":"Jung S-N, Yang WK, Kim J, Kim HS, Kim EJ, Yun H, Park H, Kim SS, Choe W, Ha J, Kang I (2008) Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 29(4):713\u2013721","journal-title":"Carcinogenesis"},{"issue":"9","key":"10274_CR93","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16(9):582\u2013598","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10274_CR94","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/ijc.24044","volume":"124","author":"JS Kasper","year":"2009","unstructured":"Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow\u2010up study. Int J Cancer 124(6):1398\u20131403","journal-title":"Int J Cancer"},{"key":"10274_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1114582","volume":"14","author":"CK Keerthana","year":"2023","unstructured":"Keerthana CK, Rayginia TP, Shifana SC, Anto NP, Kalimuthu K, Isakov N, Anto RJ (2023) The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Front Immunol 14:1114582","journal-title":"Front Immunol"},{"key":"10274_CR96","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkab023","author":"S Kelkar","year":"2021","unstructured":"Kelkar S, Oyekunle T, Eisenberg A, Howard L, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Klaassen Z, Terris MK, Freedland SJ, Csizmadi I (2021) Diabetes and prostate cancer outcomes in obese and nonobese men after radical prostatectomy. JNCI Cancer Spectr. https:\/\/doi.org\/10.1093\/jncics\/pkab023","journal-title":"JNCI Cancer Spectr"},{"issue":"8","key":"10274_CR97","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1007\/s12015-025-10956-y","volume":"21","author":"LQ Keoh","year":"2025","unstructured":"Keoh LQ, Chiu CF, Ramasamy TS (2025) Metabolic plasticity and cancer stem cell metabolism: exploring the glycolysis-OXPHOS switch as a mechanism for resistance and tumorigenesis. Stem Cell Rev Rep 21(8):2446\u20132468. https:\/\/doi.org\/10.1007\/s12015-025-10956-y","journal-title":"Stem Cell Rev Rep"},{"key":"10274_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61091577","author":"SS Khan","year":"2025","unstructured":"Khan SS, Rangraze IR, Wali AF, Jhancy M, Attia RA, Elshamly HAH, Adam S, Elbeshbeishy RAM (2025) Repurposing metformin in precision oncology: mechanistic insights, biomarker-guided strategies, and translational imperatives. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina61091577","journal-title":"Medicina (Kaunas)"},{"issue":"4","key":"10274_CR99","doi-asserted-by":"publisher","first-page":"664","DOI":"10.38212\/2224-6614.3475","volume":"31","author":"SH Khoo","year":"2023","unstructured":"Khoo SH, Wu PR, Yeh KT, Hsu SL, Wu CH (2023) Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer. J Food Drug Anal 31(4):664\u2013682. https:\/\/doi.org\/10.38212\/2224-6614.3475","journal-title":"J Food Drug Anal"},{"issue":"2","key":"10274_CR100","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s12276-026-01650-1","volume":"58","author":"TH Kim","year":"2026","unstructured":"Kim TH, Lim SH, Lee H, Chae YC, Min DS (2026) Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver. Exp Mol Med 58(2):366\u2013381","journal-title":"Exp Mol Med"},{"key":"10274_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101350","volume":"17","author":"BA Krisanits","year":"2022","unstructured":"Krisanits BA, Woods P, Nogueira LM, Woolfork DD, Lloyd CE, Baldwin A, Frye CC, Peterson KD, Cosh SD, Spruill LS, Lilly MB, Helke K, Li H, Hanna GS, Hamann MT, Thomas C, Ahmed M, Gooz MB, Findlay VJ, Turner DP, Guo Q-J (2022) Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts. Transl Oncol 17:101350","journal-title":"Transl Oncol"},{"key":"10274_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218647","volume":"655","author":"M Krishna","year":"2026","unstructured":"Krishna M, Garg P, Horne D, Salgia R, Singhal SS (2026) Inflammation-driven transcriptional reprogramming in prostate cancer: convergence of NF\u03baB, JAK\/STAT3, and epigenetic remodeling in castration-resistant disease. Cancer Lett 655:218647","journal-title":"Cancer Lett"},{"issue":"1","key":"10274_CR103","doi-asserted-by":"publisher","first-page":"10160","DOI":"10.1038\/s41467-025-65161-9","volume":"16","author":"S Krossa","year":"2025","unstructured":"Krossa S, Andersen MK, Sandholm EM, Wess M, Kiviaho A, Sharma A, Davicioni E (2025) Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment. Nat Commun 16(1):10160","journal-title":"Nat Commun"},{"issue":"15","key":"10274_CR104","first-page":"3344","volume":"58","author":"T Kubota","year":"1998","unstructured":"Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Phillip Koeffler H (1998) Ligand for peroxisome proliferator-activated receptor \u03b3 (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 58(15):3344\u20133352","journal-title":"Cancer Res"},{"key":"10274_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1168700","volume":"14","author":"CP Kung","year":"2023","unstructured":"Kung CP, Barnoud T, Yao CH, Murphy ME (2023) Editorial: double-edged swords: important factors connecting metabolic disorders and cancer development - from basic research to translational applications. Front Endocrinol (Lausanne) 14:1168700. https:\/\/doi.org\/10.3389\/fendo.2023.1168700","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10274_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071064","volume":"17","author":"W-A Kwon","year":"2025","unstructured":"Kwon W-A, Joung JY (2025) Immunotherapy in prostate cancer: from a \u201ccold\u201d tumor to a \u201chot\u201d prospect. Cancers (Basel) 17(7):1064","journal-title":"Cancers (Basel)"},{"key":"10274_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10230","volume":"7","author":"V Laurent","year":"2016","unstructured":"Laurent V, Gu\u00e9rard A, Mazerolles C, Le Gonidec S, Toulet A, Nieto L, Zaidi F, Majed B, Garandeau D, Socrier Y, Golzio M, Cadoudal T, Chaoui K, Dray C, Monsarrat B, Schiltz O, Wang YY, Couderc B, Valet P, Malavaud B, Muller C (2016) Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat Commun 7:10230. https:\/\/doi.org\/10.1038\/ncomms10230","journal-title":"Nat Commun"},{"issue":"3","key":"10274_CR108","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1158\/1541-7786.MCR-18-0748","volume":"17","author":"V Laurent","year":"2019","unstructured":"Laurent V, Toulet A, Attan\u00e9 C, Milhas D, Dauvillier S, Zaidi F, Clement E, Cinato M, Le Gonidec S, Lehu\u00e9d\u00e9 C, Garandeau D, Nieto L, Renaud-Gabardos E, Prats A-C, Valet P, Malavaud B, Muller C, Gu\u00e9rard A (2019) Periprostatic adipose tissue favors prostate cancer cell invasion in an obesity-dependent manner: role of oxidative stress. Mol Cancer Res 17(3):821\u2013835","journal-title":"Mol Cancer Res"},{"issue":"12","key":"10274_CR109","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.trecan.2019.10.012","volume":"5","author":"A Le","year":"2019","unstructured":"Le A, Udupa S, Zhang C (2019) The metabolic interplay between cancer and other diseases. Trends Cancer 5(12):809\u2013821. https:\/\/doi.org\/10.1016\/j.trecan.2019.10.012","journal-title":"Trends Cancer"},{"issue":"1","key":"10274_CR110","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","volume":"62","author":"HM Lee","year":"2013","unstructured":"Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK (2013) Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62(1):194\u2013204. https:\/\/doi.org\/10.2337\/db12-0420","journal-title":"Diabetes"},{"issue":"1","key":"10274_CR111","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1186\/s40064-016-3233-y","volume":"5","author":"J Lee","year":"2016","unstructured":"Lee J, Giovannucci E, Jeon JY (2016) Diabetes and mortality in patients with prostate cancer: a meta-analysis. Springerplus 5(1):1548. https:\/\/doi.org\/10.1186\/s40064-016-3233-y","journal-title":"Springerplus"},{"issue":"10","key":"10274_CR112","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s10552-008-9198-6","volume":"19","author":"MF Leitzmann","year":"2008","unstructured":"Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang SC, Huang W-Y, Weiss JM, Danforth KN, Grubb RL III, Andriole GL (2008) Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control 19(10):1267\u20131276. https:\/\/doi.org\/10.1007\/s10552-008-9198-6","journal-title":"Cancer Causes Control"},{"issue":"6468","key":"10274_CR113","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone RD, Zhao L, Englert JM, Sun I-M, Oh M-H, Sun I-H, Arwood ML, Bettencourt IA, Patel CH, Tam A, Blosser RL, Prchalova E, Alt J, Rais R, Slusher BS, Powell JD, Wen J (2019) Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366(6468):1013\u20131021","journal-title":"Science"},{"issue":"1","key":"10274_CR114","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12935-024-03252-1","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Huang G (2024) Insulin receptor alternative splicing in breast and prostate cancer. Cancer Cell Int 24(1):62","journal-title":"Cancer Cell Int"},{"issue":"6","key":"10274_CR115","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3724\/abbs.2023092","volume":"55","author":"D Li","year":"2023","unstructured":"Li D, Xu W, Chang Y, Xiao Y, He Y, Ren S (2023) Advances in landscape and related therapeutic targets of the prostate tumor microenvironment: therapeutic targets of the prostate tumor microenvironment. Acta Biochim Biophys Sin 55(6):956","journal-title":"Acta Biochim Biophys Sin"},{"key":"10274_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1678446","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Zhang Y, Nie Y, Chen X (2025) Immunometabolic editing of the tumor microenvironment: from reprogramming mechanisms to therapeutic vulnerabilities. Front Immunol 16:1678446","journal-title":"Front Immunol"},{"key":"10274_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1616889","volume":"17","author":"Y Li","year":"2026","unstructured":"Li Y, Lu B, Zhao Z, Gong M, Lyu D, Zhang H, Huang R, Yao Y, Liu Y, Pan X, Huang P (2026) Integrative pan-cancer analysis of dipeptidyl peptidase 4 with clinical and in vitro validation in prostate cancer. Front Immunol 17:1616889","journal-title":"Front Immunol"},{"key":"10274_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/cells14131008","author":"L Liang","year":"2025","unstructured":"Liang L, Dong D, Sun J, Zhang Q, Yang X, Wei GH, Zhang P (2025) HIF1\u03b1-PHD1-FOXA1 axis orchestrates hypoxic reprogramming and androgen signaling suppression in prostate cancer. Cells. https:\/\/doi.org\/10.3390\/cells14131008","journal-title":"Cells"},{"key":"10274_CR119","doi-asserted-by":"crossref","unstructured":"Lin H, Deng N, Li Y, Zhong J, Zou Z, Pan Z, Wang J (2025a) Spatial transcriptomics and single cell profiling reveal the dynamics of antigen presenting cancer associated fibroblasts during prostate cancer progression","DOI":"10.21203\/rs.3.rs-7219873\/v1"},{"key":"10274_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1667620","volume":"12","author":"H Lin","year":"2025","unstructured":"Lin H, Yang Y, Wang X, Chung M, Zhang L, Cai S, Pan X, Pan Y (2025b) Targeting the AGEs-RAGE axis: pathogenic mechanisms and therapeutic interventions in diabetic wound healing. Front Med 12:1667620","journal-title":"Front Med"},{"key":"10274_CR121","doi-asserted-by":"publisher","DOI":"10.2337\/dbi26-0003","author":"LL Lipscombe","year":"2026","unstructured":"Lipscombe LL, Ali S, Lega IC (2026) The link between diabetes and cancer: converging mechanistic and epidemiologic evidence. Diabetes. https:\/\/doi.org\/10.2337\/dbi26-0003","journal-title":"Diabetes"},{"key":"10274_CR122","doi-asserted-by":"crossref","unstructured":"Liu F, Beck S, Yang L, Luo H, Zhang K (2026) Advancing AI for multi-omics and clinical data integration in basic and translational cancer research. Nat Rev Cancer: 1\u201316","DOI":"10.1038\/s41568-026-00922-2"},{"issue":"3","key":"10274_CR123","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/(sici)1097-0045(20000215)42:3<239::aid-pros10>3.0.co;2-g","volume":"42","author":"W Lou","year":"2000","unstructured":"Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC (2000) Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway. Prostate 42(3):239\u2013242. https:\/\/doi.org\/10.1002\/(sici)1097-0045(20000215)42:3%3c239::aid-pros10%3e3.0.co;2-g","journal-title":"Prostate"},{"issue":"2","key":"10274_CR124","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3892\/mmr.2026.13928","volume":"34","author":"H Luo","year":"2026","unstructured":"Luo H (2026) Targeting regulatory T cells in the prostate cancer microenvironment: from mechanisms to therapeutics. Mol Med Rep 34(2):218","journal-title":"Mol Med Rep"},{"issue":"12","key":"10274_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122887","volume":"14","author":"C Luthold","year":"2022","unstructured":"Luthold C, Hallal T, Labb\u00e9 DP, Bordeleau F (2022) The extracellular matrix stiffening: a trigger of prostate cancer progression and castration resistance? Cancers (Basel) 14(12):2887","journal-title":"Cancers (Basel)"},{"key":"10274_CR126","doi-asserted-by":"publisher","first-page":"622","DOI":"10.18632\/oncotarget.28458","volume":"14","author":"D Mahalingam","year":"2023","unstructured":"Mahalingam D, Hanni S, Serritella AV, Fountzilas C, Michalek J, Hernandez B, Thompson IM (2023) Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer. Oncotarget 14:622\u2013636. https:\/\/doi.org\/10.18632\/oncotarget.28458","journal-title":"Oncotarget"},{"issue":"7203","key":"10274_CR127","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444","journal-title":"Nature"},{"issue":"25","key":"10274_CR128","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1200\/JCO.2012.46.7043","volume":"31","author":"D Margel","year":"2013","unstructured":"Margel D, Urbach DR, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, Fleshner N (2013) Metformin use and all-cause and prostate cancer\u2013specific mortality among men with diabetes. J Clin Oncol 31(25):3069\u20133075","journal-title":"J Clin Oncol"},{"issue":"4","key":"10274_CR129","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/1878-0261.70135","volume":"20","author":"A Martinez\u2010Romero","year":"2026","unstructured":"Martinez\u2010Romero A, Martinez\u2010Larrinaga A, Grego\u2010Bessa J, Garcia\u2010Longarte S, van Splunder H, Astobiza I, Ercilla A, Bozal\u2010Basterra L, Mendizabal I, Carracedo A, Graupera M, Villacampa P (2026) Aggressive prostate cancer is associated with pericyte dysfunction. Mol Oncol 20(4):947\u2013961","journal-title":"Mol Oncol"},{"issue":"2","key":"10274_CR130","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1158\/1055-9965.Epi-06-0621","volume":"16","author":"K Michalakis","year":"2007","unstructured":"Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tselenis S, Giannopoulos A, Mantzoros CS (2007) Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev 16(2):308\u2013313. https:\/\/doi.org\/10.1158\/1055-9965.Epi-06-0621","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10274_CR131","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41388-023-02875-4","volume":"43","author":"KA Miller","year":"2024","unstructured":"Miller KA, Degan S, Wang Y, Cohen J, Ku SY, Goodrich DW, Gelman IH (2024) PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression. Oncogene 43(1):22\u201334","journal-title":"Oncogene"},{"issue":"1","key":"10274_CR132","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40644-025-00938-1","volume":"25","author":"K Min","year":"2025","unstructured":"Min K, Lin Q, Qiu D (2025) Precision medicine in prostate cancer: individualized treatment through radiomics, genomics, and biomarkers. Cancer Imaging 25(1):116","journal-title":"Cancer Imaging"},{"issue":"6","key":"10274_CR133","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.urology.2006.08.1058","volume":"68","author":"A Morgentaler","year":"2006","unstructured":"Morgentaler A, Rhoden EL (2006) Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng\/mL or less. Urology 68(6):1263\u20131267","journal-title":"Urology"},{"issue":"4","key":"10274_CR134","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/imm.70096","volume":"177","author":"K Mortezaee","year":"2026","unstructured":"Mortezaee K (2026) Regulatory T cell metabolism in cancer. Immunology 177(4):686\u2013700","journal-title":"Immunology"},{"issue":"7","key":"10274_CR135","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1074\/mcp.RA119.001496","volume":"18","author":"EV Nguyen","year":"2019","unstructured":"Nguyen EV, Pereira BA, Lawrence MG, Ma X, Rebello RJ, Chan H, Niranjan B, Wu Y, Ellem S, Wu J, Skhinas JN, Cox TR, Risbridger GP, Taylor RA, Lister NL, Daly RJ, Guan X (2019) Proteomic profiling of human prostate cancer-associated fibroblasts (CAF) reveals LOXL2-dependent regulation of the tumor microenvironment. Mol Cell Proteomics 18(7):1410\u20131427","journal-title":"Mol Cell Proteomics"},{"issue":"34","key":"10274_CR136","doi-asserted-by":"publisher","first-page":"12182","DOI":"10.1073\/pnas.0804700105","volume":"105","author":"Y Niu","year":"2008","unstructured":"Niu Y, Altuwaijri S, Lai K-P, Wu C-T, Ricke WA, Messing EM, Yao J, Yeh S, Chang C (2008) Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci U S A 105(34):12182\u201312187","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10274_CR137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.2010.09804.x","author":"N Nonomura","year":"2011","unstructured":"Nonomura N, Takayama H, Nakayama M, Nakai Y, Kawashima A, Mukai M, Nagahara A, Aozasa K, Tsujimura A (2011) Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer. BJU Int. https:\/\/doi.org\/10.1111\/j.1464-410x.2010.09804.x","journal-title":"BJU Int"},{"issue":"1","key":"10274_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02202-5","volume":"21","author":"A Olatunde","year":"2021","unstructured":"Olatunde A, Nigam M, Singh RK, Panwar AS, Lasisi A, Alhumaydhi FA, Jyoti kumar V, Mishra AP, Sharifi-Rad J (2021) Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell Int 21(1):499. https:\/\/doi.org\/10.1186\/s12935-021-02202-5","journal-title":"Cancer Cell Int"},{"issue":"19","key":"10274_CR139","first-page":"5002","volume":"59","author":"AF Olumi","year":"1999","unstructured":"Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Can Res 59(19):5002\u20135011","journal-title":"Can Res"},{"issue":"1","key":"10274_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/biom13010067","volume":"13","author":"JS Owen","year":"2022","unstructured":"Owen JS, Clayton A, Pearson HB (2022) Cancer-associated fibroblast heterogeneity, activation and function: implications for prostate cancer. Biomolecules 13(1):67","journal-title":"Biomolecules"},{"issue":"2","key":"10274_CR141","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5534\/wjmh.240022","volume":"43","author":"AP Pagano","year":"2025","unstructured":"Pagano AP, da Silva BR, Vieira FT, Meira Filho LF, Purcell SA, Lewis JD, Mackenzie ML, Robson PJ, Vena JE, Silva FM, Prado CM (2025) Association between diabetes and risk of prostate cancer: a systematic review and meta-analysis of observational studies. World J Mens Health 43(2):304\u2013320. https:\/\/doi.org\/10.5534\/wjmh.240022","journal-title":"World J Mens Health"},{"issue":"3","key":"10274_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030466","volume":"17","author":"A Pandey","year":"2025","unstructured":"Pandey A, Alcaraz M Jr, Saggese P, Soto A, Gomez E, Jaldu S, Yanagawa J, Scafoglio C (2025) Exploring the role of SGLT2 inhibitors in cancer: mechanisms of action and therapeutic opportunities. Cancers 17(3):466","journal-title":"Cancers"},{"issue":"4","key":"10274_CR143","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.eururo.2023.07.016","volume":"85","author":"A Papachristodoulou","year":"2024","unstructured":"Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, Kim JY, Laplaca C, Picech F, Sch\u00e4fer G, De Castro GJ, Loda M, Klocker H, Rubin MA, Zheng T, Benson MC, McKiernan JM, Dutta A, Abate-Shen C, Hibshoosh H (2024) Metformin overcomes the consequences of NKX3. 1 loss to suppress prostate cancer progression. Eur Urol 85(4):361\u2013372","journal-title":"Eur Urol"},{"key":"10274_CR144","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7489795","author":"E Papachristoforou","year":"2020","unstructured":"Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K (2020) Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res. https:\/\/doi.org\/10.1155\/2020\/7489795","journal-title":"J Diabetes Res"},{"issue":"4","key":"10274_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/nu14040851","volume":"14","author":"JC Pardo","year":"2022","unstructured":"Pardo JC, Ruiz de Porras V, Gil J, Font A, Puig-Domingo M, Jorda M (2022) Lipid metabolism and epigenetics crosstalk in prostate cancer. Nutrients 14(4):851","journal-title":"Nutrients"},{"issue":"4","key":"10274_CR146","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4):252\u2013264","journal-title":"Nat Rev Cancer"},{"key":"10274_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","volume":"6","author":"N Patsoukis","year":"2015","unstructured":"Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell LN, Karoly ED, Freeman GJ, Petkova V, Seth P, Li L, Boussiotis VA (2015) PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun 6:6692. https:\/\/doi.org\/10.1038\/ncomms7692","journal-title":"Nat Commun"},{"issue":"23","key":"10274_CR148","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"S Pavlides","year":"2009","unstructured":"Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP, Addya S (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8(23):3984\u20134001","journal-title":"Cell Cycle"},{"issue":"11","key":"10274_CR149","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1089\/ars.2011.4243","volume":"16","author":"S Pavlides","year":"2012","unstructured":"Pavlides S, Vera I, Gandara R, Sneddon S, Pestell RG, Mercier I, Martinez-Outschoorn UE, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP (2012) Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal 16(11):1264\u20131284. https:\/\/doi.org\/10.1089\/ars.2011.4243","journal-title":"Antioxid Redox Signal"},{"key":"10274_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112396","author":"L Penfold","year":"2023","unstructured":"Penfold L, Woods A, Pollard AE, Arizanova J, Pascual-Navarro E, Muckett PJ, Dore MH, Montoya A, Whilding C, Mokochinski J, Constantin TA, Varela-Carver A, Leach DA, Bevan CL, Nikitin AY, Hall Z, Carling D, Fets L (2023) AMPK activation protects against prostate cancer by inducing a catabolic cellular state. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2023.112396","journal-title":"Cell Rep"},{"issue":"4","key":"10274_CR151","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s11302-025-10092-9","volume":"21","author":"H-X Peng","year":"2025","unstructured":"Peng H-X, Tang Y (2025) A2A receptors: a new target for immunotherapy resistance in prostate cancer. Purinergic Signal 21(4):983\u2013985","journal-title":"Purinergic Signal"},{"issue":"12","key":"10274_CR152","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","volume":"25","author":"RM Peralta","year":"2024","unstructured":"Peralta RM, Xie B, Lontos K, Nieves-Rosado H, Spahr K, Joshi S, Ford BR, Quann K, Frisch AT, Philbin M, Cillo AR, Gingras S, Poholek AC, Kane LP, Rivadeneira DB, Delgoffe GM, Dean V (2024) Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nat Immunol 25(12):2297\u20132307","journal-title":"Nat Immunol"},{"issue":"1","key":"10274_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-352","volume":"14","author":"N P\u00e9rtega-Gomes","year":"2014","unstructured":"P\u00e9rtega-Gomes N, Vizca\u00edno JR, Attig J, Jurmeister S, Lopes C, Baltazar F (2014) A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer. BMC Cancer 14(1):352","journal-title":"BMC Cancer"},{"key":"10274_CR154","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-G\u00f3mez JM, Prats-Escribano A, Gil-Duque I, Arroyo-Mill\u00e1n L, Huertas-Cabrera H, N\u00fa\u00f1ez-Santos MA, Ortea I (2026) Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2. Cell Commun Signal","DOI":"10.1186\/s12964-026-02925-w"},{"issue":"3","key":"10274_CR155","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1073\/pnas.0408894102","volume":"102","author":"JA Petros","year":"2005","unstructured":"Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim SoDug, Issa MM, Flanders WD, Marshall FF, Wallace DC, Hosseini SH (2005) mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 102(3):719\u2013724","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10274_CR156","doi-asserted-by":"crossref","unstructured":"Pierce BL (2012) Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence. In: Paper presented at the Urologic Oncology: Seminars and Original Investigations","DOI":"10.1016\/j.urolonc.2012.07.008"},{"issue":"12","key":"10274_CR157","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8(12):915\u2013928","journal-title":"Nat Rev Cancer"},{"key":"10274_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2025.128921","author":"S Pu","year":"2025","unstructured":"Pu S, Dou P, Xu T, Wei C, Li Y, Zhou L, Wang F, Lu X, Liu X, Xu G (2025) Spatial metabolomics strategy reveals heterogeneity of prostate cancer based on multi-platform imaging and laser microdissection-gas chromatography-tandem mass spectrometry. Talanta. https:\/\/doi.org\/10.1016\/j.talanta.2025.128921","journal-title":"Talanta"},{"issue":"8","key":"10274_CR159","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s41416-024-02762-z","volume":"131","author":"M Pujana-Vaquerizo","year":"2024","unstructured":"Pujana-Vaquerizo M, Bozal-Basterra L, Carracedo A (2024) Metabolic adaptations in prostate cancer. Br J Cancer 131(8):1250\u20131262","journal-title":"Br J Cancer"},{"issue":"22","key":"10274_CR160","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3390\/cells14221804","volume":"14","author":"D Qiao","year":"2025","unstructured":"Qiao D, Wang RC, Wang Z (2025) Precision oncology: current landscape, emerging trends, challenges, and future perspectives. Cells 14(22):1804","journal-title":"Cells"},{"key":"10274_CR161","doi-asserted-by":"publisher","first-page":"119670","DOI":"10.1016\/j.biopha.2026.119670","volume":"201","author":"S Qin","year":"2026","unstructured":"Qin S, An J, Qiao W, Zhichao X, Siyao T, Seo G, Kim W (2026) Resistance-centered pharmacology of DNA damage response-targeted therapy: Mechanisms, predictive biomarkers, and biomarker-guided adaptive treatment strategies in solid tumors. Biomed Pharmacother 201:119670","journal-title":"Biomed Pharmacother"},{"issue":"18","key":"10274_CR162","doi-asserted-by":"publisher","first-page":"30606","DOI":"10.18632\/oncotarget.16725","volume":"8","author":"V Quagliariello","year":"2017","unstructured":"Quagliariello V, Rossetti S, Cavaliere C, Di Palo R, Lamantia E, Castaldo L, Nocerino F, Ametrano G, Cappuccio F, Montanari M, Vanacore D, Romano FJ, Piscitelli R, Iovane G, Pepe MF, Berretta M, D\u2019Aniello C, Perdon\u00e0 S, Muto P, Botti G, Ciliberto G, Veneziani BM, De Falco F, Maiolino P, Caraglia M, Montella M, Iaffaioli RV, Facchini G, Malzone G (2017) Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences. Oncotarget 8(18):30606","journal-title":"Oncotarget"},{"issue":"6","key":"10274_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70913","volume":"40","author":"B Refaat","year":"2026","unstructured":"Refaat B, Elzubier ME, Aslam A, Idris S, Farrash WF (2026) The GLP-1 receptor agonist liraglutide promotes anticancer activities in MCF7 breast and PC-3 prostate cancer cells by modulating glycolysis, oxidative stress and adipokines. J Biochem Mol Toxicol 40(6):e70913","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"10274_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-31-32","volume":"31","author":"R Ribeiro","year":"2012","unstructured":"Ribeiro R, Monteiro C, Cunha V, Oliveira MJ, Freitas M, Fraga A, Pr\u00edncipe P, Lobato C, Lobo F, Morais A, Silva V, Sanches-Magalh\u00e3es J, Oliveira J, Pina F, Mota-Pinto A, Lopes C, Medeiros R (2012a) Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro. J Exp Clin Cancer Res 31(1):32. https:\/\/doi.org\/10.1186\/1756-9966-31-32","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"10274_CR165","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1258\/ebm.2012.012131","volume":"237","author":"R Ribeiro","year":"2012","unstructured":"Ribeiro R, Monteiro C, Silvestre R, Castela \u00c2, Coutinho H, Fraga A, Pr\u00edncipe P, Lobato C, Costa C, Lopes JM, Lopes C, Medeiros R, Cordeiro-da-Silva A (2012b) Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma. Exp Biol Med (Maywood) 237(10):1155\u20131162","journal-title":"Exp Biol Med (Maywood)"},{"issue":"11","key":"10274_CR166","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/1078-0432.Ccr-17-0894","volume":"24","author":"DB Rivadeneira","year":"2018","unstructured":"Rivadeneira DB, Delgoffe GM (2018) Antitumor T-cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy. Clin Cancer Res 24(11):2473\u20132481. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-0894","journal-title":"Clin Cancer Res"},{"key":"10274_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550500","volume":"16","author":"JP Rodr\u00edguez","year":"2025","unstructured":"Rodr\u00edguez JP, Casas J, Balboa MA, Balsinde J (2025) Bioactive lipid signaling and lipidomics in macrophage polarization: impact on inflammation and immune regulation. Front Immunol 16:1550500. https:\/\/doi.org\/10.3389\/fimmu.2025.1550500","journal-title":"Front Immunol"},{"issue":"4","key":"10274_CR168","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/carcin\/bgy012","volume":"39","author":"A Rojas","year":"2018","unstructured":"Rojas A, A\u00f1azco C, Gonz\u00e1lez I, Araya P (2018) Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Carcinogenesis 39(4):515\u2013521","journal-title":"Carcinogenesis"},{"issue":"6","key":"10274_CR169","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.ajpath.2022.03.008","volume":"192","author":"M Roumigui\u00e9","year":"2022","unstructured":"Roumigui\u00e9 M, Est\u00e8ve D, Manceau C, Toulet A, Gilleron J, Belles C, Jia Y, Hou\u00ebl C, Pericart S, Valet P, Cormont M, Tanti J-F, Malavaud B, Bouloumi\u00e9 A, Milhas D, Muller C, LeGonidec S (2022) Periprostatic adipose tissue displays a chronic hypoxic state that limits its expandability. Am J Pathol 192(6):926\u2013942","journal-title":"Am J Pathol"},{"issue":"10","key":"10274_CR170","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/ijc.24202","volume":"124","author":"MA Rowlands","year":"2009","unstructured":"Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM (2009) Circulating insulin\u2010like growth factor peptides and prostate cancer risk: a systematic review and meta\u2010analysis. Int J Cancer 124(10):2416\u20132429","journal-title":"Int J Cancer"},{"key":"10274_CR171","doi-asserted-by":"crossref","unstructured":"Ruggeri RM, Grossrubatscher EM, Arrivi G, Ciocca E, Filice A, Golisano B., Faggiano A (2026) Diabetes and cancer: glucose control impact on survival and tumor outcomes. Rev Endocr Metab Disord: 1\u201319","DOI":"10.1007\/s11154-026-10040-x"},{"key":"10274_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114168","volume":"158","author":"M Sadrkhanloo","year":"2023","unstructured":"Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Motahhary M, Saghari S, Sharifi L, Bokaie S, Mirzaei S, Entezari M, Aref AR, Salimimoghadam S, Rashidi M, Taheriazam A, Hushmandi K (2023) STAT3 signaling in prostate cancer progression and therapy resistance: an oncogenic pathway with diverse functions. Biomed Pharmacother 158:114168. https:\/\/doi.org\/10.1016\/j.biopha.2022.114168","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10274_CR173","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hynes RO, Jain RK, Janowitz T, Jorgensen C, Kimmelman AC, Kolonin MG, Maki RG, Powers RS, Pur\u00e9 E, Ramirez DC, Scherz-Shouval R, Sherman MH, Stewart S, Tlsty TD, Tuveson DA, Watt FM, Weaver V, Weeraratna AT, Werb Z, Hunter T (2020) A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20(3):174\u2013186","journal-title":"Nat Rev Cancer"},{"issue":"25","key":"10274_CR174","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","volume":"27","author":"IB Sahra","year":"2008","unstructured":"Sahra IB, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le Marchand-Brustel Y, Bost F (2008) The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 27(25):3576\u20133586","journal-title":"Oncogene"},{"issue":"1","key":"10274_CR175","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-154","volume":"14","author":"P Sanit\u00e0","year":"2014","unstructured":"Sanit\u00e0 P, Capulli M, Teti A, Galatioto GP, Vicentini C, Chiarugi P, Bologna M, Angelucci A (2014) Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression. BMC Cancer 14(1):154","journal-title":"BMC Cancer"},{"issue":"12","key":"10274_CR176","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1016\/j.bbamcr.2015.09.013","volume":"1853","author":"A Santi","year":"2015","unstructured":"Santi A, Caselli A, Ranaldi F, Paoli P, Mugnaioni C, Michelucci E, Cirri P (2015) Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth. Biochimica Et Biophysica Acta (BBA) \u2013 Mol Cell Res 1853(12):3211\u20133223","journal-title":"Biochimica Et Biophysica Acta (BBA) \u2013 Mol Cell Res"},{"issue":"2","key":"10274_CR177","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping NE, Rivadeneira DB, Menk AV, Vignali PD, Ford BR, Rittenhouse NL, Vignali PDA, Peralta R, Wang Y, Poholek AC, Delgoffe GM, DePeaux K (2021) Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol 22(2):205\u2013215","journal-title":"Nat Immunol"},{"issue":"3","key":"10274_CR178","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/pros.20707","volume":"68","author":"N Shaida","year":"2008","unstructured":"Shaida N, Launchbury R, Boddy JL, Jones C, Campo L, Turley H, Kanga S, Banham AH, Malone PR, Fox SB, Harris AL (2008) Expression of BNIP3 correlates with hypoxia\u2010inducible factor (HIF)\u20101\u03b1, HIF\u20102\u03b1 and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines. Prostate 68(3):336\u2013343","journal-title":"Prostate"},{"issue":"4","key":"10274_CR179","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s11255-024-04266-4","volume":"57","author":"N Sharma","year":"2025","unstructured":"Sharma N, Khatib MN, Balaraman AK, Roopashree R, Kaur M, Srivastava M, Barwal A, Prasad GVS, Rajput P, Syed R, Sharma G, Kumar S, Singh MP, Bushi G, Chilakam N, Pandey S, Brar M, Mehta R, Sah S, Gaidhane AM, Shabil M (2025a) Effect of GLP-1 receptor agonists on prostate cancer risk reduction: a systematic review and meta-analysis. Int Urol Nephrol 57(4):1039\u20131049. https:\/\/doi.org\/10.1007\/s11255-024-04266-4","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10274_CR180","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01829-4","volume":"16","author":"U Sharma","year":"2025","unstructured":"Sharma U, Sahu A, Shekhar H, Sharma B, Haque S, Kaur D, Tuli HS, Mishra A, Ahmad F (2025b) The heat of the battle: inflammation\u2019s role in prostate cancer development and inflammation-targeted therapies. Discov Oncol 16(1):108","journal-title":"Discov Oncol"},{"issue":"1","key":"10274_CR181","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11914-024-00897-9","volume":"23","author":"Y Shiozawa","year":"2024","unstructured":"Shiozawa Y, Parajuli KR, Pienta K, Taichman R (2024) Role of chemokines and cytokines in prostate cancer skeletal metastasis. Curr Osteoporos Rep 23(1):3. https:\/\/doi.org\/10.1007\/s11914-024-00897-9","journal-title":"Curr Osteoporos Rep"},{"issue":"22","key":"10274_CR182","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1093\/jnci\/91.22.1965","volume":"91","author":"LB Signorello","year":"1999","unstructured":"Signorello LB, Brismar K, Bergstrom R, Andersson SO, Wolk A, Trichopoulos D, Adami HO (1999) Insulin-like growth factor-binding protein-1 and prostate cancer. J Natl Cancer Inst 91(22):1965\u20131967. https:\/\/doi.org\/10.1093\/jnci\/91.22.1965","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10274_CR183","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202602229R","volume":"40","author":"V Singh","year":"2026","unstructured":"Singh V, Shirbhate E, Johariya V, Kore R, Veerasamy R, Tiwari AK, Rajak H (2026) Epigenetic-genetic crosstalk at the cancer-diabetes interface: convergent molecular pathways, multi-omics biomarkers, and dual therapeutic targets. FASEB J 40(12):e72069","journal-title":"FASEB J"},{"key":"10274_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.843458","volume":"10","author":"AP Sousa","year":"2022","unstructured":"Sousa AP, Costa R, Alves MG, Soares R, Baylina P, Fernandes R (2022) The impact of metabolic syndrome and type 2 diabetes mellitus on prostate cancer. Front Cell Dev Biol 10:843458. https:\/\/doi.org\/10.3389\/fcell.2022.843458","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10274_CR185","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/0008-5472.Can-19-2994","volume":"80","author":"P Su","year":"2020","unstructured":"Su P, Wang Q, Bi E, Ma X, Liu L, Yang M, Qian J, Yi Q (2020) Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages. Cancer Res 80(7):1438\u20131450. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-2994","journal-title":"Cancer Res"},{"issue":"12","key":"10274_CR186","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.2337\/dc12-0788","volume":"35","author":"S Suissa","year":"2012","unstructured":"Suissa S, Azoulay L (2012) Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care 35(12):2665\u20132673. https:\/\/doi.org\/10.2337\/dc12-0788","journal-title":"Diabetes Care"},{"issue":"4","key":"10274_CR187","first-page":"358","volume":"9","author":"JV Swinnen","year":"2006","unstructured":"Swinnen JV, Brusselmans K, Verhoeven G (2006) Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 9(4):358\u2013365","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10274_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101420","volume":"106","author":"Z Tang","year":"2025","unstructured":"Tang Z, Xu N, Lyu P, Zhao H, Zheng W (2025) Cross-talk between cancer and diabetes: exploring shared molecular pathways in cellular metabolism and signaling. Mol Aspects Med 106:101420","journal-title":"Mol Aspects Med"},{"issue":"1","key":"10274_CR189","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, Wilson M, Socci ND, Lash AE, Heguy A, Eastham JA, Scher HI, Reuter VE, Scardino PT, Sander C, Sawyers CL, Gerald WL, Reva B (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18(1):11\u201322","journal-title":"Cancer Cell"},{"issue":"8","key":"10274_CR190","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1158\/0008-5472.CAN-15-1551","volume":"76","author":"RC Travis","year":"2016","unstructured":"Travis RC, Appleby PN, Martin RM, Holly JM, Albanes D, Black A, Holly JMP, Bueno-de-Mesquita HB, Chan JM, Chen C, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Hamdy FC, Helzlsouer KJ, Hercberg S, Hoover RN, Janssen JAMJL, Kaaks R, Kubo T, Le Marchand L, Metter EJ, Mikami K, Morris JK, Neal DE, Neuhouser ML, Ozasa K, Palli D, Platz EA, Pollak MN, Price AJ, Roobol MJ, Schaefer C, Schenk JM, Severi G, Stampfer MJ, Stattin P, Tamakoshi A, Tangen CM, Touvier M, Wald NJ, Weiss NS, Ziegler RG, Key TJ, Allen NE, Chirlaque M-D (2016) A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk. Cancer Res 76(8):2288\u20132300","journal-title":"Cancer Res"},{"issue":"3","key":"10274_CR191","doi-asserted-by":"publisher","first-page":"616","DOI":"10.2337\/dc10-1640","volume":"34","author":"C-H Tseng","year":"2011","unstructured":"Tseng C-H (2011) Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care 34(3):616\u2013621","journal-title":"Diabetes Care"},{"issue":"2","key":"10274_CR192","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ijc.28989","volume":"136","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Allen NE, Appleby PN, Rohrmann S, N\u00f6thlings U, Arriola L, Gunter MJ, Chajes V, Rinaldi S, Murphy N, Riboli E, Tzoulaki I, Kaaks R, Lukanova A, Boeing H, Pischon T, Dahm CC, Overvad K, Quir\u00f3s JR, Fonseca-Nunes A, Molina-Montes E, Gavrila Chervase D, Ardanaz E, Khaw KT, Wareham NJ, Roswall N, Tj\u00f8nneland A, Lagiou P, Trichopoulos D, Trichopoulou A, Palli D, Pala V, Tumino R, Vineis P, Bueno-de-Mesquita HB, Malm J, Orho-Melander M, Johansson M, Stattin P, Travis RC, Key TJ, Romieu I (2015) Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 136(2):372\u2013381","journal-title":"Int J Cancer"},{"issue":"11","key":"10274_CR193","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1002\/ijc.28903","volume":"135","author":"H Uehara","year":"2014","unstructured":"Uehara H, Takahashi T, Oha M, Ogawa H, Izumi K (2014) Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression. Int J Cancer 135(11):2558\u20132568","journal-title":"Int J Cancer"},{"issue":"1","key":"10274_CR194","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2014.05.004","volume":"26","author":"T Valencia","year":"2014","unstructured":"Valencia T, Kim JY, Abu-Baker S, Moscat-Pardos J, Ahn CS, Reina-Campos M, Kim J, Ahn C, Duran A, Castilla E, Metallo C, Diaz-Meco M, Moscat J, Diaz-Meco MT (2014) Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell 26(1):121\u2013135","journal-title":"Cancer Cell"},{"issue":"4","key":"10274_CR195","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/pros.21067","volume":"70","author":"TT VanCleave","year":"2010","unstructured":"VanCleave TT, Moore JH, Benford ML, Brock GN, Kalbfleisch T, Baumgartner RN, Lillard JW, Kittles RA, Kidd LCR (2010) Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate 70(4):341\u2013352","journal-title":"Prostate"},{"key":"10274_CR196","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16183215","author":"D Vecchiotti","year":"2024","unstructured":"Vecchiotti D, Clementi L, Cornacchia E, Di Vito Nolfi M, Verzella D, Capece D, Zazzeroni F, Angelucci A (2024) Evidence of the link between stroma remodeling and prostate cancer prognosis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16183215","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10274_CR197","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/endrev\/bnad005","volume":"44","author":"V Vella","year":"2023","unstructured":"Vella V, Lappano R, Bonavita E, Maggiolini M, Clarke RB, Belfiore A, De Francesco EM (2023) Insulin\/IGF axis and the receptor for advanced glycation end products: role in meta-inflammation and potential in cancer therapy. Endocr Rev 44(4):693\u2013723","journal-title":"Endocr Rev"},{"key":"10274_CR198","doi-asserted-by":"crossref","unstructured":"Vellky J, Reizine NM, Vander Griend D (2025) GLP1R expression in prostate cancer patients and effects of GLP1R agonism on prostate cancer cells. In: American Society of Clinical Oncology","DOI":"10.1200\/JCO.2025.43.5_suppl.182"},{"issue":"23","key":"10274_CR199","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/jnci\/djm231","volume":"99","author":"V Venkateswaran","year":"2007","unstructured":"Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH, Pollak M (2007) Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst 99(23):1793\u20131800","journal-title":"J Natl Cancer Inst"},{"key":"10274_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coemr.2020.01.004","volume":"10","author":"RE Vickman","year":"2020","unstructured":"Vickman RE, Franco OE, Hayward SW (2020) Contributions of carcinoma-associated fibroblasts to the prostate cancer microenvironment. Curr Opin Endocr Metab Res 10:1\u20136","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"12","key":"10274_CR201","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1158\/1055-9965.EPI-14-0795","volume":"23","author":"AC Vidal","year":"2014","unstructured":"Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL Jr, Freedland SJ (2014) Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study. Cancer Epidemiol Biomarkers Prev 23(12):2936\u20132942","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10274_CR202","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/03915603221111125","volume":"90","author":"S Vovdenko","year":"2023","unstructured":"Vovdenko S, Morozov A, Ali S, Kogan E, Bezrukov E (2023) Role of monocarboxylate transporters and glucose transporters in prostate cancer. Urologia J 90(3):491\u2013498","journal-title":"Urologia J"},{"issue":"6","key":"10274_CR203","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/biom15060826","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen Y, Wang J (2025) Role of tumor microenvironment in prostate cancer immunometabolism. Biomolecules 15(6):826","journal-title":"Biomolecules"},{"issue":"17","key":"10274_CR204","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41388-026-03737-5","volume":"45","author":"X Wei","year":"2026","unstructured":"Wei X, Li X, Pan Y, Zhang Y, Zhong D, Kong W, Wang Y, Yu Z, Shao W, Jiang S, Qiu Z, Li Y, Gu S, Tian C, Qin C, Zhu Q, Feng N, Song N, Yao B, Yang Z, Dong Y (2026) LDHA-driven lactate metabolism promotes MDSC activation and immunosuppressive microenvironment in prostate cancer. Oncogene 45(17):1544\u20131556","journal-title":"Oncogene"},{"issue":"1","key":"10274_CR205","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/dmrr.912","volume":"25","author":"D Weinstein","year":"2009","unstructured":"Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H (2009) Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells. Diabetes Metab Res Rev 25(1):41\u201349. https:\/\/doi.org\/10.1002\/dmrr.912","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"10274_CR206","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.4161\/cc.10.11.15659","volume":"10","author":"D Whitaker-Menezes","year":"2011","unstructured":"Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, Birbe R, Howell A, Pavlides S, Gandara R, Pestell RG, Sotgia F, Philp NJ, Lisanti MP (2011) Evidence for a stromal-epithelial \u201clactate shuttle\u201d in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 10(11):1772\u20131783. https:\/\/doi.org\/10.4161\/cc.10.11.15659","journal-title":"Cell Cycle"},{"issue":"7715","key":"10274_CR207","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41586-018-0350-5","volume":"559","author":"D Wu","year":"2018","unstructured":"Wu D, Hu D, Chen H, Shi G, Fetahu IS, Wu F, Rabidou K, Fang R, Tan L, Liu H, Argueta C, Zhang L, Mao F, Yan G, Chen J, Dong Z, Lv R, Xu Y, Wang M, Ye Y, Zhang S, Duquette D, Geng S, Yin C, Lian CG, Murphy GF, Adler GK, Garg R, Lynch L, Yang P, Li Y, Lan F, Fan J, Shi Y, Shi YG, Xu S (2018) Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature 559(7715):637\u2013641","journal-title":"Nature"},{"key":"10274_CR208","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1784198","volume":"16","author":"P Wu","year":"2026","unstructured":"Wu P, Chen L, Yang J, He C, Tang A, Yang Y (2026) Mapping research trends in macrophage polarization and immunotherapeutic potential in prostate cancer: a bibliometric and visual analysis. Front Oncol 16:1784198","journal-title":"Front Oncol"},{"issue":"1","key":"10274_CR209","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04315-z","volume":"21","author":"P Xiao","year":"2023","unstructured":"Xiao P, Zhang Y, Zeng Y, Yang D, Mo J, Zheng Z, Wang J, Zhou Z, Yan W, Zhong X (2023) Impaired angiogenesis in ageing: the central role of the extracellular matrix. J Transl Med 21(1):457","journal-title":"J Transl Med"},{"key":"10274_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109674","author":"Z Xiong","year":"2024","unstructured":"Xiong Z, Yu S-L, Xie Z-X, Zhuang R-L, Peng S-R, Wang Q, Gao Z, Li B-H, Xie J-J, Li K-W, Huang H (2024a) Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis. iScience. https:\/\/doi.org\/10.1016\/j.isci.2024.109674","journal-title":"iScience"},{"key":"10274_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.12.003","author":"Z Xiong","year":"2024","unstructured":"Xiong Z, Zhuang R-L, Yu S-L, Xie Z-X, Peng S-R, Li Z-A, Li B-H, Xie J-J, Li Y-N, Huang H, Li K-W (2024b) Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2024.12.003","journal-title":"J Adv Res"},{"issue":"1","key":"10274_CR212","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00766-9","volume":"7","author":"Z Xu","year":"2021","unstructured":"Xu Z, Wang H, Qin Z, Zhao F, Zhou L, Xu L, Jia R (2021) NLRP3 inflammasome promoted the malignant progression of prostate cancer via the activation of caspase-1. Cell Death Discov 7(1):399. https:\/\/doi.org\/10.1038\/s41420-021-00766-9","journal-title":"Cell Death Discov"},{"key":"10274_CR213","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13495","author":"L Yan","year":"2025","unstructured":"Yan L, Su P, Sun X (2025) Role of multi\u2011omics in advancing the understanding and treatment of prostate cancer (review). Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2025.13495","journal-title":"Mol Med Rep"},{"key":"10274_CR214","doi-asserted-by":"crossref","unstructured":"Yan L, Chen D, Wu T, Zhao J, Xu X, Xu W, Xiao M (2026) Metformin in prostate cancer: a context-dependent antitumour strategy driven by metabolic vulnerability and signalling network. Discov Oncol","DOI":"10.1007\/s12672-026-05097-8"},{"issue":"1","key":"10274_CR215","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01516-2","volume":"8","author":"J Ye","year":"2023","unstructured":"Ye J, Cai S, Feng Y, Li J, Cai Z, Deng Y, Liu R, Zhu X, Lu J, Liang Y, Xie J, Zhang Y, He H, Han Z, Jia Z, Zhong W, Zhuo Y (2023) Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer. Signal Transduct Target Ther 8(1):303","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10274_CR216","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.18632\/aging.205886","volume":"16","author":"G-C Ye","year":"2024","unstructured":"Ye G-C, Yang Y-X, Luo K-D, Wang S-G, Xia Q-D (2024) The association between diabetes mellitus and prostate cancer: a meta-analysis and Mendelian randomization. Aging 16(11):9584","journal-title":"Aging"},{"issue":"1","key":"10274_CR217","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-026-02617-6","volume":"25","author":"H Yu","year":"2026","unstructured":"Yu H, Wang Y, He M, Chen Y, Bi J, Lin X, Cui X (2026) Integrated single-cell and spatial transcriptomic profiling decodes lineage plasticity and immune microenvironment remodeling in prostate cancer progression. Mol Cancer 25(1):88","journal-title":"Mol Cancer"},{"issue":"7","key":"10274_CR218","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1158\/1541-7786.Mcr-15-0068","volume":"13","author":"G Zadra","year":"2015","unstructured":"Zadra G, Batista JL, Loda M (2015) Dissecting the dual role of AMPK in cancer: from experimental to human studies. Mol Cancer Res 13(7):1059\u20131072. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-15-0068","journal-title":"Mol Cancer Res"},{"issue":"3","key":"10274_CR219","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41391-018-0085-2","volume":"22","author":"S Zaidi","year":"2019","unstructured":"Zaidi S, Gandhi J, Joshi G, Smith NL, Khan SA (2019) The anticancer potential of metformin on prostate cancer. Prostate Cancer Prostatic Dis 22(3):351\u2013361","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10274_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1396022","volume":"15","author":"YY Zhang","year":"2024","unstructured":"Zhang YY, Li YJ, Xue CD, Li S, Gao ZN, Qin KR (2024) Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms. Front Endocrinol (Lausanne) 15:1396022. https:\/\/doi.org\/10.3389\/fendo.2024.1396022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10274_CR221","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10250","volume":"5","author":"H Zhao","year":"2016","unstructured":"Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, Marini JC, Tudawe T, Seviour EG, Alvarez H, Gupta S, Maiti SN, Cooper L, Peehl D, Ram PT, Maitra A, Nagrath D, San Lucas FA (2016) Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife 5:e10250","journal-title":"Elife"},{"issue":"3","key":"10274_CR222","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ady5324","volume":"12","author":"D Zhao","year":"2026","unstructured":"Zhao D, Mo Z, Zhang T, Cai X, Yang Z, Chen D, Zhao J, Li Y, Zhou F, Wang J, Li Z (2026) Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer. Sci Adv 12(3):eady5324","journal-title":"Sci Adv"},{"key":"10274_CR223","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1736606","volume":"16","author":"T Zhou","year":"2025","unstructured":"Zhou T, Li Y, Liu Z, Zeng Z, Li T, Chen L, Zhao H, Wu X, Shen Y, Fan H, Zhu X, Zhou Y, Zou L, Zhao D (2025) IL-6\/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities. Front Immunol 16:1736606. https:\/\/doi.org\/10.3389\/fimmu.2025.1736606","journal-title":"Front Immunol"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10274-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-026-10274-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10274-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:02:16Z","timestamp":1788634936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-026-10274-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":222,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10274"],"URL":"https:\/\/doi.org\/10.1007\/s00335-026-10274-9","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have used Grammarly (\n                      \n                      ) for improving the language and correcting the grammatical errors within the manuscript. Additionally, all the diagrams in the manuscript were created using Biorender (\n                      \n                      ).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Research involving human participants and\/or animals","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"105"}}